查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球妇科药物市场：按治疗、适应症、分销渠道和地区划分的竞争、预测和机遇（2027 年）
市场调查报告书
商品编码
1063911

全球妇科药物市场：按治疗、适应症、分销渠道和地区划分的竞争、预测和机遇（2027 年）

Global Gynecology Drugs Market, By Therapeutics, By Indication, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 199 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球妇科药物市场预计将以 8.64% 的复合年增长率增长，2021 年达到 141.3956 亿美元，到 2027 年达到 213.9567 亿美元。

市场的主要驱动力是女性生活方式的显着变化、各种妇科癌症和疾病的患病率增加、在线销售渠道的引入以及有效治疗方法的开发，其中包括大量的投资。

从销售渠道来看，2021 年零售药店以 48.39% 的份额引领全球市场。

本报告分析了全球妇科用药市场，并详细介绍了整体市场规模趋势展望、市场份额结构（按治疗方法、适应症类型、分销渠道）、地区和主要国家。我们正在调查趋势、主要市场促进/制约因素、企业间市场竞争格局、主要企业概况、未来市场增长方向。

目录

第一章产品概述

第2章分析方法

第 3 章执行摘要

第 4 章客户的看法

  • 品牌知名度
  • 影响购买决策的因素
  • 产品偏好：按治疗

第5章COVID-19对全球妇科药品市场的影响

第6章全球妇科药物市场：未来展望

  • 市场规模及其预测
    • 金额基础
  • 市场份额及其预测
    • 按治疗方法（非激素疗法、激素疗法）
    • 按适应症（避孕、妇科感染、女性不孕症、绝经后障碍、多囊卵巢综合征、妇科癌症、子宫内膜异位症）
    • 按分销渠道（零售药店、医院药店、在线药店）
    • 按地区（北美、欧洲、亚太地区、南美、中东/非洲）
    • 按公司 (2021)
  • 产品市场图

第7章北美妇科药物市场：未来前景

  • 市场规模及其预测
  • 市场份额及其预测
  • 北美：国家/地区分析
    • 美国市场
    • 加拿大市场
    • 墨西哥市场

第8章欧洲妇科药物市场：未来前景

  • 市场规模及其预测
  • 市场份额及其预测
  • 欧洲：国家/地区分析
    • 德国市场
    • 法国市场
    • 英国市场
    • 意大利市场
    • 西班牙市场

第9章亚太妇科药物市场：未来展望

  • 市场规模及其预测
  • 市场份额及其预测
  • 亚太地区：国家/地区分析
    • 中国市场
    • 日本市场
    • 印度市场
    • 澳洲市场
    • 韩国市场

第十章南美妇科药物市场：未来展望

  • 市场规模及其预测
  • 市场份额及其预测
  • 南美洲：国家/地区分析
    • 巴西市场
    • 阿根廷市场
    • 哥伦比亚市场

第 11 章中东/非洲妇科药物市场：未来前景

  • 市场规模及其预测
  • 市场份额及其预测
  • 中东/非洲：国家/地区分析
    • 南非市场
    • 沙特阿拉伯市场
    • 阿拉伯联合酋长国 (UAE) 市场

第12章市场动态

  • 促进因素
  • 挑战

第 13 章市场趋势和走势

第14章竞争态势

  • 公司简介
    • Eli Lilly and Company Ltd.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Amgen Inc.
    • AstraZeneca Plc
    • F. Hoffmann-La Roche Ltd.
    • Allergan Plc.
    • Bayer AG
    • Abbott Laboratories Ltd.
    • AbbVie Inc.
    • GlaxoSmithKline Plc
    • Novartis Ltd.
    • Lupin Pharmaceuticals, Inc.
    • Johnson and Johnson Inc.
    • Sanofi SA

第 15 章战略建议

Product Code: 7427

The global gynecology drugs market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.

The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.

The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.

Major companies operating in the global gynecology market are: Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.

Years considered for this report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022
  • Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth and the market size of the global gynecology drugs market from 2017 to 2021.
  • To estimate and forecast the market size of the global gynecology drugs market from 2023 to 2027 and growth rate until 2027.
  • To classify and forecast the global gynecology drugs market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
  • To identify drivers and challenges for the global gynecology drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global gynecology drugs market.
  • To conduct pricing analysis for the global gynecology drugs market.
  • To identify and analyze the profile of leading players operating in global gynecology drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the global gynecology drugs market all over the world.

TechSci Research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Gynecology drugs manufacturers/ suppliers/ distributors
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to gynecology drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.

Report Scope:

In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Gynecology Drugs Market, By Therapeutics:

  • Non-Hormonal Therapy
  • Hormonal Therapy

Gynecology Drugs Market, By Indication:

  • Contraception
  • Gynecology Infections
  • Female Infertility
  • Postmenopausal disorders
  • Polycystic Ovary Syndrome
  • Osteoporosis
  • Gynecology Cancers
  • Endometriosis
  • Others (Urogenital Malformation, UTI & others)

Gynecology Drugs Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Gynecology Drugs Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness
  • 4.2. Factors Affecting Purchase Decision
  • 4.3. Product Preference, By Therapeutics

5. Impact of COVID-19 on Global Gynecology Drugs Market

6. Global Gynecology Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
    • 6.2.2. By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others)
    • 6.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
    • 6.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 6.2.5. By Company (2021)
  • 6.3. Product Market Map

7. North America Gynecology Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapeutics
    • 7.2.2. By Indication
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Gynecology Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapeutics
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Canada Gynecology Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapeutics
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Mexico Gynecology Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapeutics
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Distribution Channel

8. Europe Gynecology Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutics
    • 8.2.2. By Indication
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Gynecology Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapeutics
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. France Gynecology Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapeutics
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. United Kingdom Gynecology Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapeutics
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Italy Gynecology Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapeutics
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Spain Gynecology Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapeutics
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Distribution Channel

9. Asia Pacific Gynecology Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutics
    • 9.2.2. By Indication
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Gynecology Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutics
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Japan Gynecology Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutics
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. India Gynecology Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutics
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Distribution Channel
    • 9.3.4. Australia Gynecology Drugs Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapeutics
        • 9.3.4.2.2. By Indication
        • 9.3.4.2.3. By Distribution Channel
    • 9.3.5. South Korea Gynecology Drugs Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapeutics
        • 9.3.5.2.2. By Indication
        • 9.3.5.2.3. By Distribution Channel

10. South America Gynecology Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutics
    • 10.2.2. By Indication
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gynecology Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutics
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Argentina Gynecology Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutics
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Colombia Gynecology Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutics
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Gynecology Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutics
    • 11.2.2. By Indication
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Middle East and Africa: Country Analysis
    • 11.3.1. South Africa Gynecology Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutics
        • 11.3.1.2.2. By Indication
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutics
        • 11.3.2.2.2. By Indication
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. UAE Gynecology Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutics
        • 11.3.3.2.2. By Indication
        • 11.3.3.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

  • 14.1. Company profiles
    • 14.1.1. Eli Lilly and Company Ltd.
    • 14.1.2. Pfizer Inc.
    • 14.1.3. Merck & Co., Inc.
    • 14.1.4. Amgen Inc.
    • 14.1.5. AstraZeneca Plc
    • 14.1.6. F. Hoffmann-La Roche Ltd.
    • 14.1.7. Allergan Plc.
    • 14.1.8. Bayer AG
    • 14.1.9. Abbott Laboratories Ltd.
    • 14.1.10. AbbVie Inc.
    • 14.1.11. GlaxoSmithKline Plc
    • 14.1.12. Novartis Ltd.
    • 14.1.13. Lupin Pharmaceuticals, Inc.
    • 14.1.14. Johnson and Johnson Inc.
    • 14.1.15. Sanofi SA

15. Strategic Recommendations

List of Figures

  • Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 5: Global Gynecology Drugs Market Share, By Region, By Value, 2017-2027F
  • Figure 6: Global Gynecology Drugs Market Share, By Company, By Value, 2021
  • Figure 7: Global Gynecology Drugs Market Map, By Therapeutics, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 8: Global Gynecology Drugs Market Map, By Indication, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 9: Global Gynecology Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 10: Global Gynecology Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
  • Figure 11: North America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 12: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 13: North America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 14: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 15: North America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 16: United States Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 17: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 18: United States Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 19: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 20: Canada Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 21: Fertility Rate in Canada, 2005, 2010, 2015, 2020
  • Figure 22: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 23: Canada Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 24: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 25: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 26: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 27: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 28: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 29: Europe Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 30: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 31: Europe Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 32: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 33: Europe Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 34: Germany Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 35: Fertility Rate in Germany, 2005, 2010, 2015, 2020
  • Figure 36: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 37: Germany Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 38: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 39: France Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 40: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 41: France Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 42: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 43: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 44: Prevalence of Menopause Symptoms Experienced by Women at Work in United Kingdom, 2021
  • Figure 45: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 46: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 47: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 48: Italy Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 49: Fertility Rate in Italy, 2005, 2010, 2015, 2020
  • Figure 50: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 51: Italy Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 52: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 53: Spain Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 54: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 55: Spain Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 56: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 57: Asia Pacific Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 58: Asia Pacific Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 59: Asia Pacific Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 60: Asia Pacific Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 61: Asia Pacific Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 62: China Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 63: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 64: China Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 65: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 66: Japan Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 67: Estimated Share of Women in Japan Using any Contraceptive Method, 2005, 2010, 2015, 2020
  • Figure 68: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 69: Japan Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 70: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 71: India Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 72: Polycystic Ovary Syndrome Issues Among Women Across India, By Age Group, 2020
  • Figure 73: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 74: India Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 75: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 76: Australia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 77: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 78: Australia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 79: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 80: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 81: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 82: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 83: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 84: South America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 85: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 86: South America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 87: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 88: South America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 89: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 90: Fertility Rate in Brazil, 2005, 2010, 2015, 2020
  • Figure 91: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 92: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 93: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 94: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 95: Total Female Population of Argentina, by Age Group, 2020 (in Millions)
  • Figure 96: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 97: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 98: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 99: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 100: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 101: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 102: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 103: Middle East & Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 104: Middle East & Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 105: Middle East & Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 106: Middle East & Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 107: Middle East & Africa Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
  • Figure 108: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 109: Fertility Rate in South Africa, 2005, 2010, 2015, 2020
  • Figure 110: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 111: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 112: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 113: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 114: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 115: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 116: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
  • Figure 117: UAE Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
  • Figure 118: Total Female Population of UAE, by Age Group, 2020 (in Millions)
  • Figure 119: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
  • Figure 120: UAE Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
  • Figure 121: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F

List of Tables

  • Table 1: Infertility Statistics of United States
  • Table 2: Ovary Cancer Cases in Mexico, 2020
  • Table 3: Ovary Cancer Cases in France, 2020
  • Table 4: Ovary Cancer Cases in Spain, 2020
  • Table 5: Ovary Cancer Cases in China, 2020
  • Table 6: Cancer Statistics of Australia, 2020
  • Table 7: Ovary Cancer Cases in South Korea, 2020
  • Table 8: Ovary Cancer Cases in Colombia, 2020
  • Table 9: Cervix Uteri Cancer Cases in Saudi Arabia, 2020